StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.26+0.26 (+8.67%)

Close on Nov 18, 2026Market cap $564.44MP/E –Yield –

Entera Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Entera Bio's price to sales ratio was 393.1× on Jul 31, 2025, against 92.8× a year earlier. Over the last 5 years it ranged from 49.0× to 465.6×, with a median of 128.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025393.1×+46.9
2023Jul 31, 2023346.2×+272.4
2022Dec 30, 202273.8×−144.4
2021Dec 31, 2021218.2×+134.7
2020Dec 31, 202083.4×+34.4
2019Dec 31, 201949.0×–

More Entera Bio figures

See a number that looks wrong?